Cargando…

Anti-Mullerian Hormone as a Marker of Ovarian Reserve and Function

Background: Ovarian reserve tests are required to screen women with a diminished ovarian reserve so that women who are more likely to exhibit poor response to ovarian stimulation and a lower likelihood of becoming pregnant with treatment can be identified. Aim and Objectives: This study aimed to det...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Sudwita, Sharan, Amrita, Sinha, Sangeeta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477988/
https://www.ncbi.nlm.nih.gov/pubmed/36128562
http://dx.doi.org/10.7759/cureus.29214
_version_ 1784790480711581696
author Sinha, Sudwita
Sharan, Amrita
Sinha, Sangeeta
author_facet Sinha, Sudwita
Sharan, Amrita
Sinha, Sangeeta
author_sort Sinha, Sudwita
collection PubMed
description Background: Ovarian reserve tests are required to screen women with a diminished ovarian reserve so that women who are more likely to exhibit poor response to ovarian stimulation and a lower likelihood of becoming pregnant with treatment can be identified. Aim and Objectives: This study aimed to determine whether serum anti-Mullerian hormone (AMH) level is a better predictor of ovarian reserve and function than other biochemical tests for ovarian reserve. The primary objective of this study was to find out the correlations of day 3 serum luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, inhibin B, AMH, ovarian volume, and antral follicle count (AFC) with advancing age; and a secondary objective was to find out the correlations between day 3 serum AMH, LH, FSH, estradiol, and inhibin B levels with AFC. Methods: This was a prospective, single-center, observational study. A total of 100 infertile women who attended the Gynecology outpatient department over a period of two years and met the inclusion criteria were included in the study. History, clinical examination, routine investigations, hysterosalpingography for tubal patency, estimation of day 3 serum AMH, LH, FSH, estradiol and inhibin B, measurement of ovarian volume, and AFC were done. Correlations of different parameters with advancing age and with AFC were found using Spearman’s rho correlations. p-value < 0.05 was considered significant. Results: The maximum infertile women were in the age group of 21-30 years (58 of 100). Serum AMH showed the strongest negative correlation (r=-0.931) with age, followed by AFC (r=-0.884), ovarian volume (r=-0.876), and inhibin B (r=-0.878), whereas serum LH, FSH, and estradiol showed a positive correlation (r=0.589, 0.408, and 0.638 respectively). Serum AMH also showed a strong positive correlation (r=0.972) with AFC followed by ovarian volume (r=0.919) and inhibin B (r=0.769), whereas serum LH, FSH, and estradiol showed a negative correlation (r=-0.504, -0.663, and -0.543 respectively) with AFC.  Conclusion: Among all the different tests of ovarian reserve, serum AMH was the most reliable indicator of reproductive aging and decline in the ovarian pool as well as very closely related to AFC, which is one of the best predictors of ovarian reserve.
format Online
Article
Text
id pubmed-9477988
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-94779882022-09-19 Anti-Mullerian Hormone as a Marker of Ovarian Reserve and Function Sinha, Sudwita Sharan, Amrita Sinha, Sangeeta Cureus Medical Education Background: Ovarian reserve tests are required to screen women with a diminished ovarian reserve so that women who are more likely to exhibit poor response to ovarian stimulation and a lower likelihood of becoming pregnant with treatment can be identified. Aim and Objectives: This study aimed to determine whether serum anti-Mullerian hormone (AMH) level is a better predictor of ovarian reserve and function than other biochemical tests for ovarian reserve. The primary objective of this study was to find out the correlations of day 3 serum luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, inhibin B, AMH, ovarian volume, and antral follicle count (AFC) with advancing age; and a secondary objective was to find out the correlations between day 3 serum AMH, LH, FSH, estradiol, and inhibin B levels with AFC. Methods: This was a prospective, single-center, observational study. A total of 100 infertile women who attended the Gynecology outpatient department over a period of two years and met the inclusion criteria were included in the study. History, clinical examination, routine investigations, hysterosalpingography for tubal patency, estimation of day 3 serum AMH, LH, FSH, estradiol and inhibin B, measurement of ovarian volume, and AFC were done. Correlations of different parameters with advancing age and with AFC were found using Spearman’s rho correlations. p-value < 0.05 was considered significant. Results: The maximum infertile women were in the age group of 21-30 years (58 of 100). Serum AMH showed the strongest negative correlation (r=-0.931) with age, followed by AFC (r=-0.884), ovarian volume (r=-0.876), and inhibin B (r=-0.878), whereas serum LH, FSH, and estradiol showed a positive correlation (r=0.589, 0.408, and 0.638 respectively). Serum AMH also showed a strong positive correlation (r=0.972) with AFC followed by ovarian volume (r=0.919) and inhibin B (r=0.769), whereas serum LH, FSH, and estradiol showed a negative correlation (r=-0.504, -0.663, and -0.543 respectively) with AFC.  Conclusion: Among all the different tests of ovarian reserve, serum AMH was the most reliable indicator of reproductive aging and decline in the ovarian pool as well as very closely related to AFC, which is one of the best predictors of ovarian reserve. Cureus 2022-09-15 /pmc/articles/PMC9477988/ /pubmed/36128562 http://dx.doi.org/10.7759/cureus.29214 Text en Copyright © 2022, Sinha et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Medical Education
Sinha, Sudwita
Sharan, Amrita
Sinha, Sangeeta
Anti-Mullerian Hormone as a Marker of Ovarian Reserve and Function
title Anti-Mullerian Hormone as a Marker of Ovarian Reserve and Function
title_full Anti-Mullerian Hormone as a Marker of Ovarian Reserve and Function
title_fullStr Anti-Mullerian Hormone as a Marker of Ovarian Reserve and Function
title_full_unstemmed Anti-Mullerian Hormone as a Marker of Ovarian Reserve and Function
title_short Anti-Mullerian Hormone as a Marker of Ovarian Reserve and Function
title_sort anti-mullerian hormone as a marker of ovarian reserve and function
topic Medical Education
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477988/
https://www.ncbi.nlm.nih.gov/pubmed/36128562
http://dx.doi.org/10.7759/cureus.29214
work_keys_str_mv AT sinhasudwita antimullerianhormoneasamarkerofovarianreserveandfunction
AT sharanamrita antimullerianhormoneasamarkerofovarianreserveandfunction
AT sinhasangeeta antimullerianhormoneasamarkerofovarianreserveandfunction